Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi‐omics study integrating machine learning, mendelian randomization and mediation analysis
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Kang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Machine Learning. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: The National Nature Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Background
Diabetic nephropathy (DN), affecting 30%–40% of diabetic patients, is the leading cause of end‐stage renal disease worldwide. This study aims to identify diagnostic biomarkers and explore potential gene‐metabolite interactions in DN pathogenesis through integrated bioinformatics approaches and experimental validation.
Methods
We analysed Gene Expression Omnibus datasets through differential expression analysis, weighted gene co‐expression network analysis (WGCNA) and machine learning algorithms to identify key DN‐associated genes. The causal relationships between candidate genes and DN were investigated using Mendelian randomization (MR) analysis with cis‐expression quantitative trait loci data, which random‐effects inverse variance weighted (IVW) method was our primary analysis approach. We then employed mediating MR analysis to explore metabolite‐mediated pathways. The expression of identified genes was validated in both human DN kidney samples and diabetic mouse models.
Results
Our analysis identified seven diagnostic genes (LUM, ESM1, VCAN, LOX, G0S2, THBS2 and UMOD). Through MR analysis, THBS2 showed a significant causal association with DN outcomes (OR = 1.1653, 95% CI [1.0103, 1.3441], p = 0.0357). Subsequent mediation analysis suggested that THBS2 may influence DN development through modulation of N‐acetyl‐beta‐alanine levels (mediating effect = 17.85%, p = 0.02). Importantly, elevated THBS2 expression was confirmed in both DN patient kidney samples and diabetic mouse models, validating our bioinformatics findings.
Conclusions
Through comprehensive bioinformatics analysis and experimental validation, we identified THBS2 as a potential diagnostic marker for DN. These findings provide new insights into DN pathogenesis and suggest directions for future therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
- School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai Hospital, New York, USA.
ORCID-Profile: Kang Li, Yanqing Wang
Förderung
- The National Nature Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Li, K., Tang, H., Wang, Y., & Wang, X. (2025). Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi‐omics study integrating machine learning, mendelian randomization and mediation analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16536
Vancouver
Li K, Tang H, Wang Y, Wang X. Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi‐omics study integrating machine learning, mendelian randomization and mediation analysis. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16536
BibTeX
@article{Li2025,
author = {Li, Kang and Tang, Huidi and Wang, Yanqing and Wang, Xiaojie},
title = {Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi‐omics study integrating machine learning, mendelian randomization and mediation analysis},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16536}
}
EUVIMED